ETF Managers Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

ETF Managers Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,668	Closed	-$176K	–	873
2022 Q1	$176K	Buy	+1,668	New	+$163K	﹤0.01%	608
2021 Q3	–	Sell	-25,451	Closed	-$2.41M	–	742
2021 Q2	$2.41M	Buy	25,451 +15,417	+154%	+$1.42M	0.04%	208
2021 Q1	$874K	Buy	+10,034	New	+$847K	0.02%	292

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

ETF Managers Group's HZNP Position: Q2 2022 in Review

ETF Managers Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2022, closing a stake of 1,668 shares — an estimated $176K sold.

ETF Managers Group first reported a position in HZNP in Q1 2021 and held it in 3 quarters. The position peaked at $2.41M in Q2 2021. 614 funds tracked by Wall St. Rank hold HZNP as of Q2 2022.

ETF Managers Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2022 after selling out during the quarter.
ETF Managers Group sold 1,668 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2022, an estimated $176K.
ETF Managers Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 3 quarters.
ETF Managers Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.41M in Q2 2021.
614 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2022.

Based on ETF Managers Group's 13F filing for Q2 2022, filed 15 Aug 2022.